drugset / Trial / NCT00408915

Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion

NCT00408915

Phase 3 Completed 60 enrolled Axxonis Pharma AG
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to evaluate the long-term efficacy, local tolerability and safety of Lisuride applied as subcutaneous infusion compared to placebo in patients with advanced Parkinson's disease with motor fluctuations and "OFF" periods refractory to conventional treatment.

Timeline

Start
2006-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Lisuride Small molecule Subcutaneous

Indications